menu

CME: Shared Decision Making in Today’s Clinical Reality

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Shared Decision Making in Today’s Clinical Reality

close
0.50 credits
30 minutes
Shared Decision Making in Today’s Clinical Reality
RestartResume
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
Details
Presenters
Related
Comments
  • In Partnership with

  • Overview

    SDM is a passing fad, it is expensive, patients don’t want it and it is too time consuming. Sound familiar? Shared decision making (SDM), where clinicians and patients collaborate to make optimal healthcare decisions that align with what matters most to patients, is great in theory but difficult to translate to clinical practice. To address misconceptions and develop effective practical guidance, MD Anderson and ACHL interviewed 19 lung cancer patients and 3 caregivers to glean insights and feedback about opportunities with SDM. Three renowned thoracic oncologists discussed these findings, weigh the positives and negatives of SDM strategies considerate of a real-world setting, and share opportunities to reimagine SDM to improve outcomes for lung cancer patients.

    Find more useful and practical tools in the Quick Guide under “Related Content”. Recommendations align with both the AHRQ SHARE program and the National Quality Partners Playbook™ on shared decision making.

  • Disclosure of Conflicts of Interest

    The Accreditation Council for Continuing Medical Education has announced standards and guidelines to ensure that individuals participating in CME activities are aware of program chair(s), planning committee members, faculty/teacher/ authors, CME activity reviewer’s relationships with commercial interests that could potentially affect the information presented. The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest.

    The University of Texas MD Anderson Cancer Center has, through a formal review process, resolved all conflicts of interest prior to this activity. For information on this process, please contact CME/Conference Management at (713) 792- 5357.

    The following Faculty, Program Planning Committee Members and CME Activity Reviewers/Approvers have financial interests, arrangements or affiliations with the manufacturer of any product or devices to be discussed, or who may financially support this CME activity, as indicated below. An asterisk (*) indicates that the faculty’s presentation will include discussion of investigational or off-label uses of a product.

    Planning Committee/Faculty
    George Simon, MD
    Grant/Research Support: Merck
    Consultant: Merck, Takeda
    Membership on advisory committee: RefleXion, Genprex

    Faculty
    Howard (Jack) West, MD
    Grant/Research Support: AstraZeneca, Genentech/Roche
    Consultant: AstraZeneca
    Membership on advisory committee: Genentech/Roche

    CME Activity Reviewers/Approvers
    Cynthia Herzog, MD
    Membership on advisory committee: Merck, Sharp, Dome

    Planning Committee
    Amanda Kaczerski
    Employment: Celgene (husband employer)

    The following Faculty/Program Planning Committee Members and CME Activity Reviewers/Approvers HAVE INDICATED THEY HAVE NO FINANCIAL INTERESTS, arrangements or affiliations with the manufacturer of any product or devices to be discussed, or who may financial support this CME activity. An asterisk (*) indicates that the faculty’s presentation will include discussion of investigational or off-label uses of a product.

    Faculty
    Yasir Y. Elamin, MD
    Elizabeth Farfan-Santos, MD
    Michelle Keating, RN, OCN, MSCN

    Planning Committee
    Vanessa Senatore, Arman Nabatiyan, Tamara Greiner, MA, CHCP, Lisa Keckich, Greg Paladino

    CME Activity Reviewers/Approvers
    Diane C. Bodurka, MD, BS, MPH (approver)
    Beenu Thakral, MD
    Karin Woodman, MD

  • Target Audience

    This activity is intended for physicians, physician assistants, nurses, and any clinicians involved in the care of lung cancer patients aiming to navigate today’s clinical reality of SDM.

  • Learning Objectives

    Goals
    Maximally utilize shared decision making to ensure the patient is continually being involved with regards to their priorities and preferences in their treatment/management discussion and that the physician is aware of and discussing up-to-date treatment practices. (Knowledge, Competence, Performance)

    Employ components of shared decision making for clinical application interfacing with patients. Outline communication strategies that will assist in gathering patient involvement while discussing goals and priorities of treatment. (Knowledge, Competence, Performance)

    Implement strategies and decision aids for patients to involve them in a collaborative treatment plan discussion that takes into consideration their treatment priorities and preferences. (Competence, Performance)

    Learning Objectives
    At the conclusion of this educational activity, the participant should be able to:

    Discuss the steps of SDM and its role in the care of lung cancer patients. (Knowledge)

    Outline communication skills required to engage patients in SDM across the course of lung cancer, including diagnosis, prognosis, screening for and selection of treatment, and palliative care. (Knowledg, Competence)

    Implement strategies and decision aid methodologies to support individualized SDM. (Knowledge, Competence, Performance)

    Engage patients in discussions associated with their treatment goals, preferences, values and concerns. (Knowledge, Competence, Performance, Patient Outcomes)

  • Accreditation and Credit Designation Statements

    Accreditation/Credit Designation
    The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The University of Texas MD Anderson Cancer Center designates this enduring material activity for a maximum of .50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    CME Certificates and Attendance Certificates
    Certificates awarding AMA PRA Category 1 CreditTM or certificates documenting participation will be issued immediately to participants when an individual completes the post-test and evaluation.

    Non-Physicians will receive a certificate of participation in accordance with state nursing boards, specialty societies, or other professional associations.

  • Provider(s)/Educational Partner(s)

    Copyright© 2019 The University of Texas MD Anderson Cancer Center. All rights reserved. No part of this work can be reproduced, distributed, or otherwise used without the express permission from The University of Texas MD Anderson Cancer Center.

    All statements and opinions contained herein are solely those of the individual speakers and may not reflect those of The University of Texas MD Anderson Cancer Center.

    The University of Texas MD Anderson Cancer Center does not endorse the commercial products, equipment, or services presented by program supporters/exhibitors.

  • Commercial Support

    This activity is supported by an independent educational grant from Genentech, Inc.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • In Partnership with

  • Overview

    SDM is a passing fad, it is expensive, patients don’t want it and it is too time consuming. Sound familiar? Shared decision making (SDM), where clinicians and patients collaborate to make optimal healthcare decisions that align with what matters most to patients, is great in theory but difficult to translate to clinical practice. To address misconceptions and develop effective practical guidance, MD Anderson and ACHL interviewed 19 lung cancer patients and 3 caregivers to glean insights and feedback about opportunities with SDM. Three renowned thoracic oncologists discussed these findings, weigh the positives and negatives of SDM strategies considerate of a real-world setting, and share opportunities to reimagine SDM to improve outcomes for lung cancer patients.

    Find more useful and practical tools in the Quick Guide under “Related Content”. Recommendations align with both the AHRQ SHARE program and the National Quality Partners Playbook™ on shared decision making.

  • Disclosure of Conflicts of Interest

    The Accreditation Council for Continuing Medical Education has announced standards and guidelines to ensure that individuals participating in CME activities are aware of program chair(s), planning committee members, faculty/teacher/ authors, CME activity reviewer’s relationships with commercial interests that could potentially affect the information presented. The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest.

    The University of Texas MD Anderson Cancer Center has, through a formal review process, resolved all conflicts of interest prior to this activity. For information on this process, please contact CME/Conference Management at (713) 792- 5357.

    The following Faculty, Program Planning Committee Members and CME Activity Reviewers/Approvers have financial interests, arrangements or affiliations with the manufacturer of any product or devices to be discussed, or who may financially support this CME activity, as indicated below. An asterisk (*) indicates that the faculty’s presentation will include discussion of investigational or off-label uses of a product.

    Planning Committee/Faculty
    George Simon, MD
    Grant/Research Support: Merck
    Consultant: Merck, Takeda
    Membership on advisory committee: RefleXion, Genprex

    Faculty
    Howard (Jack) West, MD
    Grant/Research Support: AstraZeneca, Genentech/Roche
    Consultant: AstraZeneca
    Membership on advisory committee: Genentech/Roche

    CME Activity Reviewers/Approvers
    Cynthia Herzog, MD
    Membership on advisory committee: Merck, Sharp, Dome

    Planning Committee
    Amanda Kaczerski
    Employment: Celgene (husband employer)

    The following Faculty/Program Planning Committee Members and CME Activity Reviewers/Approvers HAVE INDICATED THEY HAVE NO FINANCIAL INTERESTS, arrangements or affiliations with the manufacturer of any product or devices to be discussed, or who may financial support this CME activity. An asterisk (*) indicates that the faculty’s presentation will include discussion of investigational or off-label uses of a product.

    Faculty
    Yasir Y. Elamin, MD
    Elizabeth Farfan-Santos, MD
    Michelle Keating, RN, OCN, MSCN

    Planning Committee
    Vanessa Senatore, Arman Nabatiyan, Tamara Greiner, MA, CHCP, Lisa Keckich, Greg Paladino

    CME Activity Reviewers/Approvers
    Diane C. Bodurka, MD, BS, MPH (approver)
    Beenu Thakral, MD
    Karin Woodman, MD

  • Target Audience

    This activity is intended for physicians, physician assistants, nurses, and any clinicians involved in the care of lung cancer patients aiming to navigate today’s clinical reality of SDM.

  • Learning Objectives

    Goals
    Maximally utilize shared decision making to ensure the patient is continually being involved with regards to their priorities and preferences in their treatment/management discussion and that the physician is aware of and discussing up-to-date treatment practices. (Knowledge, Competence, Performance)

    Employ components of shared decision making for clinical application interfacing with patients. Outline communication strategies that will assist in gathering patient involvement while discussing goals and priorities of treatment. (Knowledge, Competence, Performance)

    Implement strategies and decision aids for patients to involve them in a collaborative treatment plan discussion that takes into consideration their treatment priorities and preferences. (Competence, Performance)

    Learning Objectives
    At the conclusion of this educational activity, the participant should be able to:

    Discuss the steps of SDM and its role in the care of lung cancer patients. (Knowledge)

    Outline communication skills required to engage patients in SDM across the course of lung cancer, including diagnosis, prognosis, screening for and selection of treatment, and palliative care. (Knowledg, Competence)

    Implement strategies and decision aid methodologies to support individualized SDM. (Knowledge, Competence, Performance)

    Engage patients in discussions associated with their treatment goals, preferences, values and concerns. (Knowledge, Competence, Performance, Patient Outcomes)

  • Accreditation and Credit Designation Statements

    Accreditation/Credit Designation
    The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The University of Texas MD Anderson Cancer Center designates this enduring material activity for a maximum of .50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    CME Certificates and Attendance Certificates
    Certificates awarding AMA PRA Category 1 CreditTM or certificates documenting participation will be issued immediately to participants when an individual completes the post-test and evaluation.

    Non-Physicians will receive a certificate of participation in accordance with state nursing boards, specialty societies, or other professional associations.

  • Provider(s)/Educational Partner(s)

    Copyright© 2019 The University of Texas MD Anderson Cancer Center. All rights reserved. No part of this work can be reproduced, distributed, or otherwise used without the express permission from The University of Texas MD Anderson Cancer Center.

    All statements and opinions contained herein are solely those of the individual speakers and may not reflect those of The University of Texas MD Anderson Cancer Center.

    The University of Texas MD Anderson Cancer Center does not endorse the commercial products, equipment, or services presented by program supporters/exhibitors.

  • Commercial Support

    This activity is supported by an independent educational grant from Genentech, Inc.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Programs 2/17/20